Ua piʻi aʻe ʻo Boston Scientific i 20%, ua piʻi aʻe ʻo Medtronic i 8%, ua hāʻule ʻo Fuji Health i 2.9%, a ua hāʻule ʻo Olympus Kina i 23.9%.
Ua hoʻāʻo wau e kālailai i ka hana kūʻai aku o kekahi mau ʻoihana ma nā wahi nui o ka honua ma o kā lākou mau hōʻike kālā e hoʻomaopopo i ka mākeke lapaʻau (a i ʻole endoscopy) a pehea e wehewehe ai nā lama like ʻole i kā lākou huahana a me nā lawelawe ma Kina. ʻO ka pahuhopu ka ʻike ʻana i nā loli e hoʻopilikia ana i ka loaʻa kālā.
Ke ʻImi ʻana i nā Mea Maʻamau: ʻAʻole i hōʻike ʻia kahi hoʻohālikelike ākea o nā loli o ka loaʻa kālā ma nā wahi like ʻole no nā hui multinational like ʻole i kahi ʻano maopopo. Inā he ʻano, ʻoi aku ka maikaʻi o nā kūʻai aku ma ko lākou mau ʻāina home, me ka emi nui ʻana ma Kina i hoʻohālikelike ʻia me ka manawa like i ka makahiki i hala. Ua ʻoi aku ka maikaʻi o nā mākeke e kū mai ana ma Asia (koe naʻe ʻo Kina) ma mua o ʻEulopa. Ua ʻike ʻia ka mana o Kina ma nā hui multinational ma nā lako a me nā mea hoʻopau waiwai nui, me nā lako e hōʻike ana i kahi hopena nui aʻe. Ma ka manaʻo o nā hui multinational e loea ana i nā mea hoʻopau waiwai kiʻekiʻe, ʻo ʻAmelika Hui Pū ʻIa ka mākeke nui loa, ukali ʻia e ʻEulopa a me Iapana. Ua ʻōlelo ʻia ʻo Kina he mākeke e kū mai ana ma muli o VBP (Vacuum-Based Pharmaceutical Products). ʻO kekahi mea maʻamau, ʻo ia ka manaʻo nui i ka ulu ʻana o ka organik (nā huahana hou, ka hana hou, ka ulu ʻana o ka mea hoʻohana) ma waena o nā hui multinational. Ua hoʻoikaika lākou i ka hana hou a me nā hoʻolālā huahana i hoʻokaʻawale ʻia ma nā wahi e pili ana i nā pae like ʻole o ka hoʻomohala lapaʻau. Ua ʻōlelo pū ʻo Medtronic lāua ʻo Olympus i ka robotics, e hōʻike ana i kona hopena i nā ʻoihana e kū nei. Loaʻa i nā hui ʻelua nā ʻoihana e pili ana i ka AI.
Inā hoihoi ʻoe, e ʻoluʻolu e heluhelu no kahi loiloi kikoʻī.
Ke nānā aku iā Fuji, me he mea lā ua pālahalaha ka mākeke, akā ke emi nei nā mea āpau ma waho o Iapana, me ʻEulopa e ʻike nei i ka emi wikiwiki loa. Ke nānā aku iā Obama, me he mea lā ma ka honua holoʻokoʻa, koe wale nō ʻo ʻAsia a me Oceania (koe naʻe ʻo Iapana a me Kina), ke ʻike nei nā mea āpau i nā emi nui, ʻoiai ʻo Kina a me ʻAmelika ʻĀkau. Ke nānā aku nei iā Boston Scientific lāua ʻo Medtronic, me he mea lā he mea hoʻohiki maikaʻi loa ke kūlana honua.
Ua ulu ka loaʻa kālā o Fujifilm no Q1 2025 (ʻApelila-Iune), me nā kāmela kalepa, ma ka 0.1% holoʻokoʻa, me 7.4% ma Iapana, -0.1% ma ʻAmelika Hui Pū ʻIa, -6.9% ma ʻEulopa, a me -3.6% ma ʻAsia a me nā wahi ʻē aʻe.
Ma ka ʻāpana mālama ola kino, ʻaʻohe wehewehe ʻana o nā kūʻai aku ma ka ʻāpana ʻoihana i hāʻawi ʻia; ʻo nā helu wale nō o ka hui holoʻokoʻa i loaʻa. ʻO ka loaʻa kālā mālama ola kino he ¥228.5 biliona, he 2.9% ka emi ʻana o kēlā me kēia makahiki. Ua emi ke kūʻai aku ʻana o nā mea lapaʻau (kiʻiʻoniʻoni) ma Kina (ma muli paha o ka emi ʻana o ke koi?), A ua emi pū nā lako diagnostic X-ray (ma muli paha o ka emi ʻana o nā kauoha nui i kēia hapaha i hoʻohālikelike ʻia me ka makahiki i hala, i ka wā i ʻoi aku ai nā kauoha nui). E pili ana i nā endoscopes, ua loaʻa i ka moʻo ELUXEO 8000 nā kūʻai ikaika ma ʻEulopa i Mei 2025; akā naʻe, ua noho palahalaha ka mākeke endoscope holoʻokoʻa i hoʻohālikelike ʻia me ka makahiki i hala, ʻoiai ua loaʻa nā kauoha koʻikoʻi ma Turkey a me ʻAmelika Waena a me ʻAmelika Hema.
ʻO ka ulu holoʻokoʻa o Olympus no ʻApelila-Iune 2025 he -12.1% (Iapana -8.9%, ʻAmelika ʻĀkau -18.9%, ʻEulopa -7.5%, Kina -23.9%, ʻĀsia (koe naʻe ʻo Kina a me Iapana) a me Oceania 7.62%, nā wahi ʻē aʻe 17.8%). Ua pili ka emi ʻana ma ʻEulopa i ka emi ʻana o nā endoscope ʻoki kino, i wehewehe ʻia e ka nui o nā kauoha i kau ʻia ma ʻEulopa i ka manawa like i ka makahiki i hala, he wehewehe like me kā Fujifilm. He hoʻomohala maikaʻi ka ʻōnaehana VISERA ELITE III i ke ʻoki kino ʻEulopa, akā ʻaʻole i hana pinepine ʻia ka gastroscopy a me ka colonoscopy i loko o ka lumi hana. No ka hoʻoponopono ʻana i ka emi ʻana o ka loaʻa kālā, ke hoʻokō ʻia nei ka hoʻemi ʻana i ke kumukūʻai ma ka hōʻemi ʻana i nā kumukūʻai manawa hoʻokahi ʻole a me ka hoʻonui ʻana i ka hoʻonohonoho lilo. ʻO ka hoʻonui ʻana i kona kapuaʻi ʻenehana lapaʻau a me ka hoʻokele ʻana i ka hoʻomohala ʻana ma ke kahua o ka endoscopic robotics e hoʻokō i ka ulu ʻana o ka loaʻa kālā i ka wā e hiki mai ana ma kēia wahi. Ke hoʻoikaika nei ʻo Olympus i nā laulima kūwaho a me nā hoʻopukapuka kālā ma o nā ʻoihana like: Ma Iulai 25, 2025, ua komo ka Hui, ma o kāna lālā i hui pū ʻia ʻo Olympus Corporation of the Americas, i kahi ʻaelike hoʻopukapuka kālā me Revival Healthcare Capital LLC e hoʻokumu pū i ka ʻoihana like ʻo Swan EndoSurgical, Inc., e kālele ana i ka noiʻi a me ka hoʻomohala ʻana i nā huahana robotic endoscopic.
Boston Scientific: No Iulai-Kepakemapa 2025, ua ulu ka loaʻa kālā he 20.3% i kēlā me kēia makahiki, me ka ulu ʻana o ka ʻoihana lapaʻau a me ke ʻoki kino he 16.4% (urology 28.1%, endoscopy 10.1%, neurology 9.1%), ka ulu ʻana o ka organik 7.6%, a me ka ulu ʻana o ka ʻoihana cardiovascular he 22.4%, ka ulu ʻana o ka organik 19.4%. ʻAʻohe ʻike i hāʻawi ʻia e pili ana iā Kina, e haʻi wale ana ua alakaʻi ka VBP (centralized procurement) ma Kina i ka emi ʻana o ka loaʻa kālā interventional peripheral, e hopena ana i ka emi ʻana o hoʻokahi helu wale nō. Ua hōʻike ka ʻoihana endoscopic intraluminal iā AXIOS™ (stent) a me OverStitch™ (suture), e hōʻike ana i ka loaʻa kālā koʻikoʻi o Boston Scientific mai nā huahana hou.
Ua piʻi ka loaʻa kālā o ʻAmelika Hui Pū ʻIa ma 27%, ʻoi aku ma mua o 65% o ka loaʻa kālā o ka honua.
ʻEulopa, Hikina Waena, a me ʻApelika (EMEA): Ua ulu ke kūʻai aku ma 2.6%.
ʻEulopa: ʻO ke kumu nui, ʻo ia ka hoʻoholo a ka ʻoihana ma Q2 2025 e hoʻopau i ke kūʻai aku honua o nā ʻōnaehana valve aortic ACURATE neo2™ a me ACURATE Prime™, kahi i loaʻa ai ma kahi o $50 miliona i nā kūʻai aku hapaha honua i ka manawa like i ka makahiki i hala. Inā ʻaʻole i hoʻopau ʻia ke kūʻai aku, ua hiki ka ulu ʻana o Q3 i ka 9% ma muli o kēia helu. Ua paʻa mau ke koi no nā lawelawe endoscopic intracavitary (AXIOS™, OverStitch™) a me ka hoʻoulu ʻana i ka lolo hohonu (DBS).
ʻĀkia Pākīpika (APAC): Ka ulu ʻana o 17.1%, i hoʻokele nui ʻia e Iapana, kahi mākeke oʻo.
ʻAmelika Latina a me Kanada (LACA): Ka ulu ʻana o 10.4%.
Nā Mākeke Kū i ka Honua: Ka ulu ʻana o 11.8%.
ʻO ka ulu ʻana o Medtronic's Q1 2025 he 8.4% holoʻokoʻa, me ka ulu ʻana o ka ʻoihana cardiovascular he 9.3%, neurology 4.3%, a me ke ʻoki kino 4.4%. (Ua ʻike ʻia ka ulu ʻana o ka organik ma Surgical & Endoscopy he 2.3%, me ka ʻenehana pani vascular LigaSure™ e mālama ana i ka māhele mākeke no ka hapaha 12 i ka lālani, e hoʻokō ana i ka ulu honua kiʻekiʻe hoʻokahi-helu; akā naʻe, ua kaupalena ʻia ka ulu ʻana e nā kaomi pōkole mai ke koi paʻa no ke ʻoki kino bariatric ma ka mākeke US a me ka hoʻololi ʻana i ke ʻoki kino kuʻuna e ke ʻoki kino robotic. ʻO ka hoʻolālā ʻana o ka hoʻomaka ʻana o ka robot Hugo™ ma US (i ka hapa lua o ka makahiki) e lilo i mea nui no ka ulu ʻana i kēia ʻāpana i ka wā e hiki mai ana.) Ua ulu ka ʻoihana maʻi diabetes he 11.5%.
Ma ka ʻāpana: US$4.24 biliona, he piʻi ʻana o 3.5%, e helu ana i 49% o ka mākeke honua. Ua ulu nā mākeke honua he 13.6%, me ka ulu ʻana o ka cardiovascular he 12.6%, neurology 5.4%, ʻoki kino lapaʻau 7.5%, a me ka maʻi diabetes 16.7%. Ua hoʻokele ʻia ka ulu ʻana ma ka mākeke honua e ka mākeke Kepani (cardiac ablation, TAVR), ka mākeke ʻEulopa (neuromodulation, robotic surgery), a me nā mākeke e kū mai ana (nā lako hana ʻoki kino kumu, nā mea ʻike maʻi diabetes). Ua kālele ka mākeke US i ka hoʻolaha ʻana i nā huahana hou waiwai nui (e like me PFA, RDN). (Hoʻomākaukau), ke kālele nei ka mākeke honua i ka "komo ʻana i loko o nā mākeke e kū mai ana + ka piʻi ʻana o ka māhele mākeke ma nā mākeke makua" (e like me PFA ma Iapana a me TAVR ma ʻEulopa), e hoʻokō ana i nā pono hoʻohui ma nā wahi like ʻole. Ua hoʻokuʻu ʻo Medtronic i kahi ʻāpana endoscopy digestive i kōkua ʻia e AI.
E pili ana iā Kina, ma ka ʻāpana "Neurovascular" wale nō, ua ʻōlelo ka palapala "e lanakila mālie ʻia ka hopena o ka hopena kumu o ke kūʻai ʻana ma muli o ka nui o Kina (VBP) a me nā hoʻihoʻi huahana."
Ua komo mua nā huahana kiʻekiʻe i ka mākeke US, me ka ulu lohi ma ʻEulopa a me ka ulu nui ma nā mākeke ʻĀsia e kū mai ana. Me he mea lā he manaʻo maka akua ko nā hui multinational; ma hope o ka hoʻololi ʻana i nā huahana ma US, hana hou ʻia kēia ʻano ma ʻEulopa a me ʻAsia. Loaʻa ka ulu ʻana mai ka hana hou a i ʻole ka loaʻa ʻana o ka hana hou, akā ua hoʻopilikia ʻia e nā pōʻaiapuni mana, nā pilikia o ka hana hou, a me ka mana o ka robotics (ua piʻi ka loaʻa kālā honua o Intuitive Surgical ma 23% i ka Q3, a ua piʻi ka nui o ke ʻoki kino ma 19%). Me he mea lā ʻaʻole ikaika loa ka ulu ʻana o nā endoscopes.
ʻO mākou, ʻo Jiangxi Zhuoruihua Medical Instrument Co., Ltd., he mea hana ma Kina e loea ana i nā mea hoʻopau endoscopic, me ka laina GI e like menā forceps biopsy, hemoclip,ʻūpā polyp, nila sclerotherapy, ʻaukā pīpī, nā palaki cytology, uea alakaʻi, hīnaʻi kiʻi pōhaku, cathete hoʻokahe wai nasal biliary etc. i hoʻohana nui ʻia maEMR, ESD, ERCPA me ka Urology Line, e like meʻūpā komo uretera me ka ʻūpā komo ureteral me ka omo,0
Ua hōʻoia ʻia kā mākou huahana e CE, a ua hōʻoia ʻia kā mākou mau mea kanu e ISO. Ua hoʻokuʻu ʻia aku kā mākou waiwai i ʻEulopa, ʻAmelika ʻĀkau, Hikina Waena a me kekahi ʻāpana o ʻAsia, a ua loaʻa nui ka ʻike a me ka hoʻomaikaʻi ʻia e ka mea kūʻai aku!
ZRHmed、Nā forceps biopsy:、Hemoclip、ʻūpā polyp、nila sclerotherapy、ʻO ka catheter pīpī、nā palaki cytology、ʻUea alakaʻi、hīnaʻi kiʻi pōhaku、catheter hoʻokahe wai biliary ihu、EMR、ESD、ERCP、UAS me ka Suction、ʻUpena komo Ureteral、Hīnaʻi Hoʻihoʻi Pōhaku Mimi Hoʻolei ʻia、ʻUra alakaʻi Urology
Ka manawa hoʻouna: Dec-23-2025